Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

CVTX CV Therapeutics (MM)

20.01

0.00 (0.00%)

Jul 11 2024 - Closed

Delayed by 15 minutes

JACC Publishes MARISA Trial Results, Including Anti-Ischemic and Long-Term Survival Data

JACC Publishes MARISA Trial Results, Including Anti-Ischemic and Long-Term Survival Data PALO ALTO, Calif., April 20 /PRNewswire-FirstCall/ -- Data from the Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) trial showing that Ranexa(TM) (ranolazine) produced statistically significant (p

CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jun 2024 to Jul 2024